Intelligent Antibody Discovery

Therapeutic monoclonal antibodies for medicine

Abeome is a privately-held antibody discovery company focused on the high-throughput selection, analysis and synthesis of monoclonal antibodies with a primary objective to develop best-in-class prescription products for the therapeutic antibody market – the fastest growing segment of global drug sales.

Read More »

Recent News

Abeome Honored by Georgia Bio for AbeoMouse™

Abeome Corporation announced today it has been named a Georgia Bio Innovation Award Winner.

Abeome Closes $2M Angel Round

Abeome Corporation announced today the closing of a $2M Angel Round.